# LEROCHOL

NDC: 84685-300
Generic name: lerodalcibep-liga
Labeler / Manufacturer: LIB Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251215

FDA application: BLA761427

## Active ingredients

- LERODALCIBEP: 300 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84685-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84685-300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=422f8b04-6ce8-4e64-a0a9-0ccc9a4a5860